Spruce Biosciences names Jessica Cohen Pfeffer vice president, clinical development

PUBT · 2d ago
Spruce Biosciences names Jessica Cohen Pfeffer vice president, clinical development
  • Spruce Biosciences appointed Jessica Cohen Pfeffer as vice president, clinical development, effective today.
  • She previously spent over a decade at BioMarin, most recently as executive medical director leading clinical sciences for Brineura.
  • Pfeffer supported key regulatory milestones for enzyme replacement therapies, including approvals in the US, Europe, and the UK.
  • Spruce is advancing a planned BLA submission for tralesinidase alfa enzyme replacement therapy in Sanfilippo Syndrome Type B.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spruce Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608030800BIZWIRE_USPR_____20260803_BW685552) on August 03, 2026, and is solely responsible for the information contained therein.